BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Williams HC, Bath-hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS. Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. Journal of Investigative Dermatology 2017;137:614-9. [DOI: 10.1016/j.jid.2016.10.019] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 14.4] [Reference Citation Analysis]
Number Citing Articles
1 Seidl-Philipp M, Frischhut N, Höllweger N, Schmuth M, Nguyen VA. Known and new facts on basal cell carcinoma. J Dtsch Dermatol Ges 2021;19:1021-41. [PMID: 34288482 DOI: 10.1111/ddg.14580] [Reference Citation Analysis]
2 Pitney T, Muir J. Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial". J Am Acad Dermatol 2021;84:e55. [PMID: 32860912 DOI: 10.1016/j.jaad.2020.08.093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Bichakjian CK, Alam M. Reply to: "Comment on 'Guidelines of care for the management of basal cell carcinoma'". J Am Acad Dermatol 2018;79:e101. [PMID: 29981388 DOI: 10.1016/j.jaad.2018.06.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Jia H, He Y. Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial. Journal of Dermatological Treatment 2020;31:831-8. [DOI: 10.1080/09546634.2019.1638883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Islam MA, Rice J, Reesor E, Zope H, Tao W, Lim M, Ding J, Chen Y, Aduluso D, Zetter BR, Farokhzad OC, Shi J. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice. Biomaterials 2021;266:120431. [PMID: 33099060 DOI: 10.1016/j.biomaterials.2020.120431] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
6 Plachouri K, Balasis S, Mallioris AF, Koumoundourou D, Georgiou S. Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream. Dermatologic Therapy 2018;31:e12685. [DOI: 10.1111/dth.12685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Kamath P, Darwin E, Arora H, Nouri K. A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas. Clin Drug Investig 2018;38:883-99. [PMID: 30128748 DOI: 10.1007/s40261-018-0681-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kakkassery V, Emmert S, Adamietz IA, Kovács G, Jünemann AM, Otte C, Zimbelmann M, Brosig A, Grisanti S, Heindl LM. [Alternative treatment options for periorbital basal cell carcinoma]. Ophthalmologe 2020;117:113-23. [PMID: 31811367 DOI: 10.1007/s00347-019-01021-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Adan F, Nelemans PJ, Essers BAB, Brinkhuizen T, Dodemont SRP, Kessels JPHM, Quaedvlieg PJF, Dermont G, Winnepenninckx VJL, Abdul Hamid M, Kelleners-smeets NWJ, Mosterd K. Optical coherence tomography versus punch biopsy for diagnosis of basal cell carcinoma: a multicentre, randomised, non-inferiority trial. The Lancet Oncology 2022;23:1087-96. [DOI: 10.1016/s1470-2045(22)00347-3] [Reference Citation Analysis]
10 Mahatma G, Sweeney AR, Yen MT. Imiquimod for Superficial Basal Cell Carcinomas. International Ophthalmology Clinics 2020;60:3-11. [DOI: 10.1097/iio.0000000000000299] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Voiculescu VM, Lisievici CV, Lupu M, Vajaitu C, Draghici CC, Popa AV, Solomon I, Sebe TI, Constantin MM, Caruntu C. Mediators of Inflammation in Topical Therapy of Skin Cancers. Mediators Inflamm 2019;2019:8369690. [PMID: 30766448 DOI: 10.1155/2019/8369690] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
12 Collier NJ, Rhodes LE. Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities. Molecules 2020;25:E5398. [PMID: 33218174 DOI: 10.3390/molecules25225398] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Williams HC, Rogers NK, Chalmers JR, Thomas KS. Scoping the international impact from four independent national dermatology trials. Clin Exp Dermatol 2021;46:657-62. [PMID: 33179251 DOI: 10.1111/ced.14506] [Reference Citation Analysis]
14 Koerner J, Horvath D, Groettrup M. Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy. Front Immunol 2019;10:707. [PMID: 31024545 DOI: 10.3389/fimmu.2019.00707] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
15 Kang A, Zhao D, Yeh JJ, Lee DJ. Updates on Immunotherapy for the Treatment of Skin Cancer. Curr Derm Rep 2018;7:311-20. [DOI: 10.1007/s13671-018-0246-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Kash N, Silapunt S. A review of emerging and non-US FDA-approved topical agents for the treatment of basal cell carcinoma. Future Oncol 2021;17:3111-32. [PMID: 34156307 DOI: 10.2217/fon-2020-1147] [Reference Citation Analysis]
17 Ferrante di Ruffano L, Dinnes J, Chuchu N, Bayliss SE, Takwoingi Y, Davenport C, Matin RN, O'Sullivan C, Roskell D, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults. Cochrane Database Syst Rev 2018;12:CD013187. [PMID: 30521689 DOI: 10.1002/14651858.CD013187] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 van Delft LC, Jansen MH, Mosterd K, Kelleners-smeets NW. Comment on “Guidelines of care for the management of basal cell carcinoma”. Journal of the American Academy of Dermatology 2018;79:e99-e100. [DOI: 10.1016/j.jaad.2018.05.1261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Singh M, Mehta Grewal A, Singh H, Sharma M, Kaur M, Gupta P, Zadeng Z. Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas. Eur J Ophthalmol 2021;:11206721211035614. [PMID: 34320864 DOI: 10.1177/11206721211035614] [Reference Citation Analysis]
20 Jalalat S, Agoris C, Fenske NA, Cherpelis B. Management of Non-melanoma Skin Cancers: Basal Cell Carcinoma, Squamous Cell Carcinoma. In: Riker AI, editor. Melanoma. Cham: Springer International Publishing; 2018. pp. 591-604. [DOI: 10.1007/978-3-319-78310-9_37] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Mahajan S, Kalaivani M, Sethuraman G, Khaitan BK, Verma KK, Gupta S. A retrospective comparative study of outcome with surgical excision and repair versus nonsurgical and ablative treatments for basal cell carcinoma. Indian J Dermatol Venereol Leprol 2021;87:348-56. [PMID: 33666033 DOI: 10.25259/IJDVL_170_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Dinnes J, Deeks JJ, Chuchu N, Saleh D, Bayliss SE, Takwoingi Y, Davenport C, Patel L, Matin RN, O'Sullivan C, Patalay R, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group. Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults. Cochrane Database Syst Rev 2018;12:CD013191. [PMID: 30521687 DOI: 10.1002/14651858.CD013191] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
23 Fukumoto T, Fukumoto R, Oka M, Horita N. Comparing treatments for basal cell carcinoma in terms of long‐term treatment‐failure: a network meta‐analysis. J Eur Acad Dermatol Venereol 2019;33:2050-7. [DOI: 10.1111/jdv.15796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Chuchu N, Dinnes J, Takwoingi Y, Matin RN, Bayliss SE, Davenport C, Moreau JF, Bassett O, Godfrey K, O'Sullivan C, Walter FM, Motley R, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group. Teledermatology for diagnosing skin cancer in adults. Cochrane Database Syst Rev 2018;12:CD013193. [PMID: 30521686 DOI: 10.1002/14651858.CD013193] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
25 Montuno MA, Coldiron BM. Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma. JAMA Dermatol 2019;155:394-5. [PMID: 30725082 DOI: 10.1001/jamadermatol.2018.3719] [Reference Citation Analysis]
26 Totonchy M, Leffell D. Emerging concepts and recent advances in basal cell carcinoma. F1000Res 2017;6:2085. [PMID: 29259776 DOI: 10.12688/f1000research.11314.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
27 Ferrante di Ruffano L, Dinnes J, Deeks JJ, Chuchu N, Bayliss SE, Davenport C, Takwoingi Y, Godfrey K, O'Sullivan C, Matin RN, Tehrani H, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group. Optical coherence tomography for diagnosing skin cancer in adults. Cochrane Database Syst Rev 2018;12:CD013189. [PMID: 30521690 DOI: 10.1002/14651858.CD013189] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
28 Tanese K. Diagnosis and Management of Basal Cell Carcinoma. Curr Treat Options Oncol 2019;20:13. [PMID: 30741348 DOI: 10.1007/s11864-019-0610-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
29 Jansen MHE, Mosterd K, Arits AHMM, Roozeboom MH, Sommer A, Essers BAB, van Pelt HPA, Quaedvlieg PJF, Steijlen PM, Nelemans PJ, Kelleners-Smeets NWJ. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma. J Invest Dermatol 2018;138:527-33. [PMID: 29045820 DOI: 10.1016/j.jid.2017.09.033] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 12.2] [Reference Citation Analysis]
30 Singh M, Singh H, Kakkar N, Zadeng Z, Gupta P. Treatment of squamous cell carcinoma of the eyelid with imiquimod 5% cream. Canadian Journal of Ophthalmology 2019;54:e24-7. [DOI: 10.1016/j.jcjo.2018.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
31 Nasr I, McGrath EJ, Harwood CA, Botting J, Buckley P, Budny PG, Fairbrother P, Fife K, Gupta G, Hashme M, Hoey S, Lear JT, Mallipeddi R, Mallon E, Motley RJ, Newlands C, Newman J, Pynn EV, Shroff N, Slater DN, Exton LS, Mohd Mustapa MF, Ezejimofor MC; British Association of Dermatologists’ Clinical Standards Unit. British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021. Br J Dermatol 2021. [PMID: 34050920 DOI: 10.1111/bjd.20524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Thomson J, Hogan S, Leonardi-Bee J, Williams HC, Bath-Hextall FJ. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2020;11:CD003412. [PMID: 33202063 DOI: 10.1002/14651858.CD003412.pub3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Slominski AT, Brożyna AA, Zmijewski MA, Janjetovic Z, Kim TK, Slominski RM, Tuckey RC, Mason RS, Jetten AM, Guroji P, Reichrath J, Elmets C, Athar M. The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers. Adv Exp Med Biol 2020;1268:257-83. [PMID: 32918223 DOI: 10.1007/978-3-030-46227-7_13] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
34 Azzopardi EA, Abdelrahman W, Azzopardi E, O'Leary B, Yarrow J, Miles N, Barbara C, Camilleri L, Clementoni MT, Murison M. Treatment of cutaneous basal cell carcinoma with combined laser extirpation and methyl aminolevulinic acid: five-year success rates. Ann R Coll Surg Engl 2021;103:263-71. [PMID: 33557701 DOI: 10.1308/rcsann.2020.7020] [Reference Citation Analysis]
35 Cameron MC, Lee E, Hibler BP, Giordano CN, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM. Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention. J Am Acad Dermatol 2019;80:321-39. [PMID: 29782901 DOI: 10.1016/j.jaad.2018.02.083] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 11.5] [Reference Citation Analysis]
36 Chen OM, Kim K, Steele C, Wilmas KM, Aboul-fettouh N, Burns C, Doan HQ, Silapunt S, Migden MR. Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma. Cancers 2022;14:3720. [DOI: 10.3390/cancers14153720] [Reference Citation Analysis]
37 Dinnes J, Deeks JJ, Chuchu N, Matin RN, Wong KY, Aldridge RB, Durack A, Gulati A, Chan SA, Johnston L, Bayliss SE, Leonardi-Bee J, Takwoingi Y, Davenport C, O'Sullivan C, Tehrani H, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults. Cochrane Database Syst Rev 2018;12:CD011901. [PMID: 30521688 DOI: 10.1002/14651858.CD011901.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
38 Jansen MHE, Sinx KAE, Kelleners-Smeets NWJ, Mosterd K. Commentary on "Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma". Dermatol Surg 2019;45:144-5. [PMID: 29406490 DOI: 10.1097/DSS.0000000000001492] [Reference Citation Analysis]
39 Kofler L, Häfner HM, Schulz C, Eichner M, Kofler K, Schnabl SM, Breuninger H. [Surgical techniques in the treatment of basal cell carcinoma-a prospective investigation]. Hautarzt 2020;71:960-8. [PMID: 32930855 DOI: 10.1007/s00105-020-04685-1] [Reference Citation Analysis]
40 Paoli J, Gyllencreutz JD, Fougelberg J, Backman EJ, Modin M, Polesie S, Zaar O. Nonsurgical Options for the Treatment of Basal Cell Carcinoma. Dermatol Pract Concept 2019;9:75-81. [PMID: 31106008 DOI: 10.5826/dpc.0902a01] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
41 van Delft LC, Nelemans PJ, Jansen MH, Arits AH, Roozeboom MH, Hamid MA, Mosterd K, Kelleners-smeets NW. Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study. Journal of the American Academy of Dermatology 2019;80:1022-8. [DOI: 10.1016/j.jaad.2018.12.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
42 Lang BM, Balermpas P, Bauer A, Blum A, Brölsch GF, Dirschka T, Follmann M, Frank J, Frerich B, Fritz K, Hauschild A, Heindl LM, Howaldt HP, Ihrler S, Kakkassery V, Klumpp B, Krause-Bergmann A, Löser C, Meissner M, Sachse MM, Schlaak M, Schön MP, Tischendorf L, Tronnier M, Vordermark D, Welzel J, Weichenthal M, Wiegand S, Kaufmann R, Grabbe S. S2k-Leitlinie Basalzellkarzinom der Haut - Teil 2: Therapie, Prävention und Nachsorge. J Dtsch Dermatol Ges 2019;17:214-31. [PMID: 30762951 DOI: 10.1111/ddg.13755_g] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
43 Vijay V, Alam MS, Subramanian N, Krishnakumar S, Biswas J, Mukherjee B. Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India. Oman J Ophthalmol 2020;13:129-35. [PMID: 33542600 DOI: 10.4103/ojo.OJO_130_2019] [Reference Citation Analysis]
44 Greenspan A, Popik S. Comment on "Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics". J Am Acad Dermatol 2019;81:e45. [PMID: 30930086 DOI: 10.1016/j.jaad.2019.03.068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
45 Sinx KAE, Nelemans PJ, Kelleners-Smeets NWJ, Winnepenninckx VJL, Arits AHMM, Mosterd K. Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial. J Am Acad Dermatol 2020;83:469-76. [PMID: 32320773 DOI: 10.1016/j.jaad.2020.04.053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
46 Niculet E, Craescu M, Rebegea L, Bobeica C, Nastase F, Lupasteanu G, Stan DJ, Chioncel V, Anghel L, Lungu M, Tatu AL. Basal cell carcinoma: Comprehensive clinical and histopathological aspects, novel imaging tools and therapeutic approaches (Review). Exp Ther Med 2022;23:60. [PMID: 34917186 DOI: 10.3892/etm.2021.10982] [Reference Citation Analysis]
47 Cullen JK, Simmons JL, Parsons PG, Boyle GM. Topical treatments for skin cancer. Adv Drug Deliv Rev 2020;153:54-64. [PMID: 31705912 DOI: 10.1016/j.addr.2019.11.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
48 Axon E, Grindlay DJ. Letter to the editor submitted in response to “efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a Meta-analysis of randomised controlled trial”. Journal of Dermatological Treatment 2021;32:410-410. [DOI: 10.1080/09546634.2019.1659478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Kus KJB, Ruiz ES. Non-Surgical Treatments for Keratinocyte Carcinomas. Adv Ther 2021;38:5635-48. [PMID: 34652721 DOI: 10.1007/s12325-021-01916-2] [Reference Citation Analysis]
50 Dinnes J, Bamber J, Chuchu N, Bayliss SE, Takwoingi Y, Davenport C, Godfrey K, O'Sullivan C, Matin RN, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group. High-frequency ultrasound for diagnosing skin cancer in adults. Cochrane Database Syst Rev 2018;12:CD013188. [PMID: 30521683 DOI: 10.1002/14651858.CD013188] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
51 Li M, Zhang X, Duan X, Cao X, Zhao H. A meta‐analysis of treatment effects of imiquimod for basal cell carcinoma. J Cosmet Dermatol 2020;19:218-25. [DOI: 10.1111/jocd.13119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Kim S, Youssef SH, Song Y, Garg S. Development and application of a chromatographic method for simultaneous quantification of 5-fluorouracil and imiquimod in drug-in-adhesive topical patches. Sustainable Chemistry and Pharmacy 2022;27:100711. [DOI: 10.1016/j.scp.2022.100711] [Reference Citation Analysis]
53 Padya BS, Pandey A, Pisay M, Koteshwara KB, Chandrashekhar Hariharapura R, Bhat KU, Biswas S, Mutalik S. Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer. Eur J Pharmacol 2021;890:173633. [PMID: 33049302 DOI: 10.1016/j.ejphar.2020.173633] [Reference Citation Analysis]
54 Greig A, Aloni K, Orchard G, Shams M, Craythorne E, Fassihi H. Treatment of multiple facial basal cell carcinomas in a child with xeroderma pigmentosum complementation group C with Mohs micrographic surgery. Br J Dermatol 2021;184:e4. [PMID: 33325539 DOI: 10.1111/bjd.19323] [Reference Citation Analysis]
55 Kofler L, Breuninger H, Schreiber RH, Eichner M, Häfner HM, Schnabl SM. Three-dimensional histology vs. serial section histology in the treatment of primary basal cell carcinoma: a randomized, prospective, blinded study of 569 tumours. J Eur Acad Dermatol Venereol 2021;35:1323-30. [PMID: 33539573 DOI: 10.1111/jdv.17155] [Reference Citation Analysis]
56 Iftimia N, Sahu A, Cordova M, Maguluri G, Gill M, Alessi-Fox C, Gonzalez S, Navarrete-Dechent C, Marghoob A, Chen CJ, Rajadhyaksha M. The potential utility of integrated reflectance confocal microscopy-optical coherence tomography for guiding triage and therapy of basal cell carcinomas. J Cancer 2020;11:6019-24. [PMID: 32922542 DOI: 10.7150/jca.47026] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Thomson J, Hogan S, Leonardi-Bee J, Williams HC, Bath-Hextall FJ. Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments. Br J Dermatol 2021;185:499-511. [PMID: 33448328 DOI: 10.1111/bjd.19809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Wysong A, Higgins S, Blalock TW, Ricci D, Nichols R, Smith FL, Kossintseva I. Defining skin cancer local recurrence. Journal of the American Academy of Dermatology 2019;81:581-99. [DOI: 10.1016/j.jaad.2019.03.087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
59 Sabri AH, Cater Z, Gurnani P, Ogilvie J, Segal J, Scurr DJ, Marlow M. Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma. International Journal of Pharmaceutics 2020;589:119808. [DOI: 10.1016/j.ijpharm.2020.119808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
60 Seidl-Philipp M, Frischhut N, Höllweger N, Schmuth M, Nguyen VA. Bekanntes und Neues zum Basalzellkarzinom. J Dtsch Dermatol Ges 2021;19:1021-43. [PMID: 34288462 DOI: 10.1111/ddg.14580_g] [Reference Citation Analysis]
61 Lang BM, Balermpas P, Bauer A, Blum A, Brölsch GF, Dirschka T, Follmann M, Frank J, Frerich B, Fritz K, Hauschild A, Heindl LM, Howaldt HP, Ihrler S, Kakkassery V, Klumpp B, Krause-Bergmann A, Löser C, Meissner M, Sachse MM, Schlaak M, Schön MP, Tischendorf L, Tronnier M, Vordermark D, Welzel J, Weichenthal M, Wiegand S, Kaufmann R, Grabbe S. S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up. J Dtsch Dermatol Ges 2019;17:214-30. [PMID: 30762963 DOI: 10.1111/ddg.13755] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
62 Manoli SM, Moutsoudis A, Papageorgiou C, Lallas K, Rigas HM, Kyrmanidou E, Papadimitriou I, Paschou E, Spyridis I, Gkentsidi T, Sotiriou E, Vakirlis E, Ioannidis D, Apalla Z, Lallas A. Real-life data on basal cell carcinoma treatment: Insights on clinicians' therapeutic choices from an institutional hospital registry. Dermatol Ther 2020;33:e14414. [PMID: 33064345 DOI: 10.1111/dth.14414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Ferrante di Ruffano L, Takwoingi Y, Dinnes J, Chuchu N, Bayliss SE, Davenport C, Matin RN, Godfrey K, O'Sullivan C, Gulati A, Chan SA, Durack A, O'Connell S, Gardiner MD, Bamber J, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group. Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults. Cochrane Database Syst Rev 2018;12:CD013186. [PMID: 30521691 DOI: 10.1002/14651858.CD013186] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
64 Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, Bataille V, Marmol VD, Dummer R, Harwood CA, Hauschild A, Höller C, Haedersdal M, Malvehy J, Middleton MR, Morton CA, Nagore E, Stratigos AJ, Szeimies R, Tagliaferri L, Trakatelli M, Zalaudek I, Eggermont A, Grob JJ. Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines. European Journal of Cancer 2019;118:10-34. [DOI: 10.1016/j.ejca.2019.06.003] [Cited by in Crossref: 93] [Cited by in F6Publishing: 82] [Article Influence: 31.0] [Reference Citation Analysis]
65 Sinx KAE, van Loo E, Tonk EHJ, Kelleners-Smeets NWJ, Winnepenninckx VJL, Nelemans PJ, Mosterd K. Optical Coherence Tomography for Noninvasive Diagnosis and Subtyping of Basal Cell Carcinoma: A Prospective Cohort Study. J Invest Dermatol 2020;140:1962-7. [PMID: 32147505 DOI: 10.1016/j.jid.2020.01.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Kelleners-Smeets NWJ, Mosterd K, Nelemans PJ. Treatment of Low-Risk Basal Cell Carcinoma. J Invest Dermatol 2017;137:539-40. [PMID: 28235442 DOI: 10.1016/j.jid.2016.11.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
67 van Delft LCJ, Kelleners-Smeets NWJ. Interventions for basal cell carcinoma: from evidence to personalized treatment. Br J Dermatol 2021;185:475. [PMID: 33822380 DOI: 10.1111/bjd.20059] [Reference Citation Analysis]
68 Sabri A, Ogilvie J, McKenna J, Segal J, Scurr D, Marlow M. Intradermal Delivery of an Immunomodulator for Basal Cell Carcinoma; Expanding the Mechanistic Insight into Solid Microneedle-Enhanced Delivery of Hydrophobic Molecules. Mol Pharm 2020;17:2925-37. [PMID: 32510228 DOI: 10.1021/acs.molpharmaceut.0c00347] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
69 Ramelyte E, Restivo G, Mannino M, Levesque MP, Dummer R. Advances in the drug management of basal cell carcinoma. Expert Opin Pharmacother 2022;:1-10. [PMID: 35081851 DOI: 10.1080/14656566.2022.2032646] [Reference Citation Analysis]
70 van Delft LCJ, van Loo E, Mosterd K, Kelleners-Smeets NWJ. Comment on "Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines". Eur J Cancer 2020;131:98-9. [PMID: 31932177 DOI: 10.1016/j.ejca.2019.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Olabi B, Tasker F, Williams HC. 'Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial': a critical appraisal. Br J Dermatol 2020;183:650-4. [PMID: 31977075 DOI: 10.1111/bjd.18891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
72 Vijay V, Alam M, Subramanian N, Krishnakumar S, Biswas J, Mukherjee B. Periocular basal cell carcinoma: 20-years experience at a tertiary eye care center of South India. Oman J Ophthalmol 2020;13:129. [DOI: 10.4103/ojo.ojo_130_2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Liu Q, Li P, Yang Z, Qu B, Qin C, Meng S, Fang H, Wu R, Cheng T, Yang D. Multi-stage surgery combined with radiotherapy for treatment of giant anterior chest wall keloid: A case report. Medicine (Baltimore) 2020;99:e18886. [PMID: 31977896 DOI: 10.1097/MD.0000000000018886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]